Thomas Hollenbeck
Genomics Institute of the Novartis Research Foundation(US)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Analytical Chemistry and Chromatography, Mass Spectrometry Techniques and Applications, Bone Metabolism and Diseases, Adenosine and Purinergic Signaling
Most-Cited Works
- → Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents(2011)103 cited
- → Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents(2012)92 cited
- → Nanoelectrospray Mass Spectrometry and Precursor Ion Monitoring for Quantitative Steroid Analysis and Attomole Sensitivity(1999)84 cited
- → Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases(2017)51 cited
- → Lead Optimization of Imidazopyrazines: A New Class of Antimalarial with Activity on Plasmodium Liver Stages(2014)33 cited
- → Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers(2006)31 cited
- → Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors(2006)23 cited
- → Preparative mass spectrometry with electrospray ionization(1999)22 cited
- → Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S(2007)17 cited
- → Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl(2006)16 cited